Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Valvular Heart Disease

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 209 articles:
HTML format
Text format



Single Articles


    September 2018
  1. DADU RT, Xu J, Rehman H, von Ballmoos MW, et al
    Optimal positioning of self-expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27829.
    PubMed     Text format     Abstract available


  2. RASHID HN, Nasis A, Gooley RP, Cameron JD, et al
    The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prostheses.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27702.
    PubMed     Text format     Abstract available


  3. VAN MOURIK MS, Janmaat YC, van Kesteren F, Vendrik J, et al
    CT determined psoas muscle area predicts mortality in women undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27823.
    PubMed     Text format     Abstract available


  4. BRAUN D, Nabauer M, Massberg S, Hausleiter J, et al
    One-stop shop: Simultaneous direct mitral annuloplasty and percutaneous mitral edge-to-edge repair in a patient with severe mitral regurgitation.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27848.
    PubMed     Text format     Abstract available


  5. GORLA R, Cannone GS, Bedogni F, De Marco F, et al
    Transfemoral aortic valve implantation following lithoplasty of iliac artery in a patient with poor vascular access.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27812.
    PubMed     Text format     Abstract available


    August 2018
  6. ATTISANO T, Silverio A, Stabile E, Briguori C, et al
    Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: The "BAV for life" experience.
    Catheter Cardiovasc Interv. 2018 Aug 25. doi: 10.1002/ccd.27820.
    PubMed     Text format     Abstract available


  7. AZIZ M, Simonato M, Webb JG, Abdel-Wahab M, et al
    Mortality prediction after transcatheter treatment of failed bioprosthetic aortic valves utilizing various international scoring systems: Insights from the Valve-in-Valve International Data (VIVID).
    Catheter Cardiovasc Interv. 2018 Aug 5. doi: 10.1002/ccd.27714.
    PubMed     Text format     Abstract available


  8. LLOYD JW, Reeder GS, Rihal CS, Eleid MF, et al
    Effect of saline administration on left atrial pressure during transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Aug 5. doi: 10.1002/ccd.27710.
    PubMed     Text format     Abstract available


  9. KHAN JM, Lederman RJ
    Adventures across the second dimension: Predicting left ventricular outflow tract obstruction following transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2018;92:388-389.
    PubMed     Text format    


  10. LEMOS PA, Makdisse M
    The less complex the case is, the more complex is it to choose? The case of lower risk patients with aortic valve stenosis.
    Catheter Cardiovasc Interv. 2018;92:399-400.
    PubMed     Text format    


  11. CHATTERJEE A, Hillegass WB
    Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption.
    Catheter Cardiovasc Interv. 2018;92:431-432.
    PubMed     Text format    


    July 2018
  12. TAM DY, Vo TX, Wijeysundera HC, Dvir D, et al
    Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 19. doi: 10.1002/ccd.27686.
    PubMed     Text format     Abstract available


  13. ROGERS T, Gai J, Torguson R, Okubagzi PG, et al
    Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27668.
    PubMed     Text format     Abstract available


  14. MAKKI N, Ghao X, Whitson B, Shreenivas S, et al
    Slope of left ventricular filling as an index of valvular and paravalvular regurgitation in native and prosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27684.
    PubMed     Text format     Abstract available


  15. UESHIMA D, Nai Fovino L, Mojoli M, Napodano M, et al
    The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27681.
    PubMed     Text format     Abstract available


  16. DAMLUJI AA, Murman M, Byun S, Moscucci M, et al
    Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
    Catheter Cardiovasc Interv. 2018 Jul 3. doi: 10.1002/ccd.27690.
    PubMed     Text format     Abstract available


    June 2018
  17. BLOCK PC
    Transcatheter treatment of aortic regurgitation: Still enigmatic.
    Catheter Cardiovasc Interv. 2018;91:1352-1353.
    PubMed     Text format     Abstract available


    May 2018
  18. HACHINOHE D, Latib A, Montorfano M, Colombo A, et al
    Transcatheter mitral valve implantation in rigid mitral annuloplasty rings: Potential differences between complete and incomplete rings.
    Catheter Cardiovasc Interv. 2018 May 18. doi: 10.1002/ccd.27658.
    PubMed     Text format     Abstract available


  19. ASMARATS L, Rodriguez-Gabella T, Chamandi C, Bernier M, et al
    Infective endocarditis following transcatheter edge-to-edge mitral valve repair: A systematic review.
    Catheter Cardiovasc Interv. 2018 May 10. doi: 10.1002/ccd.27632.
    PubMed     Text format     Abstract available


    April 2018
  20. VILLABLANCA PA, Mohananey D, Ramakrishna H
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Apr 16. doi: 10.1002/ccd.27639.
    PubMed     Text format    


  21. SAJI M, Katz MR, Ailawadi G, Welch TS, et al
    6-Minute walk test predicts prolonged hospitalization in patients undergoing transcatheter mitral valve repair by MitraClip.
    Catheter Cardiovasc Interv. 2018 Apr 15. doi: 10.1002/ccd.27600.
    PubMed     Text format     Abstract available


  22. DE BACKER O, Sondergaard L
    TAVR in bicuspid aortic valve stenosis: "We are not there yet" to draw final conclusions.
    Catheter Cardiovasc Interv. 2018;91:984-985.
    PubMed     Text format     Abstract available


    March 2018
  23. YE J, Lee AJ, Blanke P, Webb J, et al
    The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27604.
    PubMed     Text format     Abstract available


  24. KINDYA B, Ouzan E, Lerakis S, Gonen E, et al
    Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27607.
    PubMed     Text format     Abstract available


  25. HONDA Y, Yamawaki M, Araki M, Tada N, et al
    Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27596.
    PubMed     Text format     Abstract available


  26. DE PALMA R, Settergren M, Ruck A, Linder R, et al
    Impact of percutaneous femoral arteriotomy closure using the MANTA(TM) device on vascular and bleeding complications after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27595.
    PubMed     Text format     Abstract available


  27. TAKAHASHI M, Badenco N, Monteau J, Gandjbakhch E, et al
    Impact of pacemaker mode in patients with atrioventricular conduction disturbance after trans-catheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Mar 14. doi: 10.1002/ccd.27594.
    PubMed     Text format     Abstract available


  28. EITAN A, Witt J, Stripling J, Haselbach T, et al
    Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli >/=26 mm.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27588.
    PubMed     Text format     Abstract available


  29. ABDELGHANI M, de Winter RJ, Miyazaki Y, Modolo R, et al
    Determinants of success and hemodynamic impact of balloon postdilatation of self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27538.
    PubMed     Text format     Abstract available


    February 2018
  30. SARAF S, Cockburn J, Alsanjari O, Hildick-Smith D, et al
    Transcatheter aortic valve implantation via the superficial femoral artery: An underused access route?
    Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27544.
    PubMed     Text format     Abstract available


  31. AZARRAFIY R, Albuquerque FN, Carrillo RG, Cohen MG, et al
    Coil embolization to successfully treat annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27546.
    PubMed     Text format     Abstract available


  32. HIOKI H, Watanabe Y, Kozuma K, Yamamoto M, et al
    Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27547.
    PubMed     Text format     Abstract available


  33. KHAN JM, Rogers T, Schenke WH, Greenbaum AB, et al
    Transcatheter pledget-assisted suture tricuspid annuloplasty (PASTA) to create a double-orifice valve.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27531.
    PubMed     Text format     Abstract available


  34. FACCINI A, Butera G
    Tricuspid regurgitation as a complication of Edwards Sapien XT valve implantation in pulmonary position a problem to deal with.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27527.
    PubMed     Text format     Abstract available


  35. LIU X, He Y, Zhu Q, Gao F, et al
    Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2018 Feb 5. doi: 10.1002/ccd.27467.
    PubMed     Text format     Abstract available


  36. TAKAGI H, Mitta S, Ando T
    Long-term survival after transcatheter versus surgical aortic valve replacement for aortic stenosis: A meta-analysis of observational comparative studies with a propensity-score analysis.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27521.
    PubMed     Text format     Abstract available


  37. WITBERG G, Lador A, Yahav D, Kornowski R, et al
    Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27518.
    PubMed     Text format     Abstract available


    January 2018
  38. SCHAFER U, Kalbacher D, Voigtlander L, Conradi L, et al
    First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27466.
    PubMed     Text format     Abstract available


  39. TSURUTA H, Hayashida K, Yashima F, Yanagisawa R, et al
    Incidence, predictors, and midterm clinical outcomes of left ventricular obstruction after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27508.
    PubMed     Text format     Abstract available


  40. EL SABBAGH A, Eleid MF, Matsumoto JM, Anavekar NS, et al
    Three-dimensional prototyping for procedural simulation of transcatheter mitral valve replacement in patients with mitral annular calcification.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27488.
    PubMed     Text format     Abstract available


  41. KAGASE A, Yamamoto M, Shimura T, Kodama A, et al
    Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: A propensity-matched analysis.
    Catheter Cardiovasc Interv. 2018 Jan 11. doi: 10.1002/ccd.27483.
    PubMed     Text format     Abstract available


  42. GARCIA S, Kelly R, Mbai M, Gurevich S, et al
    Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Catheter Cardiovasc Interv. 2018 Jan 9. doi: 10.1002/ccd.27478.
    PubMed     Text format     Abstract available


  43. ALASTI M, Rashid H, Rangasamy K, Kotschet E, et al
    Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27463.
    PubMed     Text format     Abstract available


  44. AMAT-SANTOS IJ, Rojas P, Gutierrez H, Vera S, et al
    Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
    Catheter Cardiovasc Interv. 2018 Jan 3. doi: 10.1002/ccd.27485.
    PubMed     Text format     Abstract available


    December 2017
  45. GOLDSWEIG AM, Kennedy KF, Kolte D, Abbott JD, et al
    Predictors of patient radiation exposure during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27452.
    PubMed     Text format     Abstract available


  46. HACHINOHE D, Latib A, Agricola E, Colombo A, et al
    Repeat MitraClip for early recurrent mitral regurgitation.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27460.
    PubMed     Text format     Abstract available


  47. WANG DD, Eng MH, Greenbaum AB, Myers E, et al
    Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27447.
    PubMed     Text format     Abstract available


  48. PATEL JS, Krishnaswamy A, White J, Mick S, et al
    Optimizing hemodynamics of transcatheter aortic valve-in-valve implantation in 19-mm surgical aortic prostheses.
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27415.
    PubMed     Text format     Abstract available


  49. NAKAJIMA Y, Kar S
    First experience of the usage of a GORE CARDIOFORM Septal Occluder device for treatment of a significant residual commissural mitral regurgitation jet following a MitraClip procedure.
    Catheter Cardiovasc Interv. 2017 Dec 8. doi: 10.1002/ccd.27438.
    PubMed     Text format     Abstract available


  50. MILLAN-ITURBE O, Sawaya FJ, Lonborg J, Chow DHF, et al
    Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Catheter Cardiovasc Interv. 2017 Dec 7. doi: 10.1002/ccd.27440.
    PubMed     Text format     Abstract available


  51. RASHID HN, McCormick LM, Talman AH, Ihdayhid AR, et al
    Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
    Catheter Cardiovasc Interv. 2017 Dec 6. doi: 10.1002/ccd.27378.
    PubMed     Text format     Abstract available


  52. SHATILA W, Krajcer Z
    A cardiologist's nightmare: Coronary obstruction during transcatheter aortic valve implantation: How to identify patients at highest risk for this complication.
    Catheter Cardiovasc Interv. 2017;90:1198-1199.
    PubMed     Text format     Abstract available


    November 2017
  53. SILASCHI M, Conradi L, Wendler O, Schlingloff F, et al
    The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27370.
    PubMed     Text format     Abstract available


  54. ELEID MF, Reeder GS, Rihal CS
    Comparison of left atrial pressure monitoring with dedicated catheter versus steerable guiding catheter during transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27430.
    PubMed     Text format     Abstract available


  55. ALKHALIL A, Golbari S, Song D, Lamba H, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27433.
    PubMed     Text format     Abstract available


  56. TRENKWALDER T, Pellegrini C, Holzamer A, Philipp A, et al
    Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27385.
    PubMed     Text format     Abstract available


  57. MAYR NP, Wiesner G, Hapfelmeier A, van der Starre P, et al
    Periprocedural transfusion in patients undergoing transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27382.
    PubMed     Text format     Abstract available


  58. SCHOECHLIN S, Brennemann T, Allali A, Ruile P, et al
    Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1-year mortality.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27384.
    PubMed     Text format     Abstract available


  59. FANARI Z, Mahmaljy H, Nandish S, Goswami NJ, et al
    Simultaneous transcatheter transfemoral aortic and transeptal mitral valve replacement using Edward SAPIEN S3.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27410.
    PubMed     Text format     Abstract available


  60. ALMEIDA JG, Ferreira SM, Fonseca P, Dias T, et al
    Comparison of self-expanding and balloon-expandable transcatheter aortic valves morphology and association with paravalvular regurgitation: Evaluation using multidetector computed tomography.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27401.
    PubMed     Text format     Abstract available


    October 2017
  61. ARORA S, Vaidya SR, Strassle PD, Misenheimer JA, et al
    Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27357.
    PubMed     Text format     Abstract available


  62. FLUECKIGER P, Singleton M, Vasu S, Zhao D, et al
    Bioprosthetic tricuspid valve thrombosis: Percutaneous PFO closure to improve hypoxia and respiratory failure.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27217.
    PubMed     Text format     Abstract available


  63. TUMMALA R, Banerjee K, Sankaramangalam K, Mick S, et al
    Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27398.
    PubMed     Text format     Abstract available


  64. STEINBERG ZL, Morray BH, Jones TK
    Bicaval Medtronic Melody valve implantation for treatment of severe mitral regurgitation following the Mustard repair: A case report.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27373.
    PubMed     Text format     Abstract available


  65. DE PALMA R, Ruck A, Settergren M, Saleh N, et al
    Percutaneous axillary arteriotomy closure during transcatheter aortic valve replacement using the MANTA device.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27383.
    PubMed     Text format     Abstract available


  66. SHOEIB O, Burzotta F, Aurigemma C, Paraggio L, et al
    Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27248.
    PubMed     Text format     Abstract available


  67. DRAFTS BC, Choi CH, Sangal K, Cammarata MW, et al
    Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27377.
    PubMed     Text format     Abstract available


  68. ANDO T, Akintoye E, Telila T, Briasouolis A, et al
    Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Catheter Cardiovasc Interv. 2017 Oct 9. doi: 10.1002/ccd.27362.
    PubMed     Text format     Abstract available


  69. HTUN WW, Grines C, Schreiber T
    Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27346.
    PubMed     Text format     Abstract available


  70. CARRERAS ET, Kaneko T, Ramirez-Del Val F, Pelletier MP, et al
    Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27347.
    PubMed     Text format     Abstract available


  71. DALL'ARA G, Santarelli A, Marzocchi A, Bacchi Reggiani ML, et al
    Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices.
    Catheter Cardiovasc Interv. 2017 Oct 5. doi: 10.1002/ccd.27328.
    PubMed     Text format     Abstract available


  72. FRANKEN M, Lemos PA
    Treating of aortic valve stenosis in real-life: A multifaceted decision-making challenge.
    Catheter Cardiovasc Interv. 2017;90:671-672.
    PubMed     Text format     Abstract available


    September 2017
  73. REDDY G, Wang Z, Nishimura RA, Greason KL, et al
    Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27340.
    PubMed     Text format     Abstract available


  74. ANDO T, Briasoulis A, Telila T, Afonso L, et al
    Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27336.
    PubMed     Text format     Abstract available


  75. ALQAHTANI F, Aljohani S, Almustafa A, Alhijji M, et al
    Comparative outcomes of transcatheter aortic valve replacement in African American and Caucasian patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Sep 23. doi: 10.1002/ccd.27257.
    PubMed     Text format     Abstract available


  76. DREXEL T, Helmer G, Garcia S, Raveendran G, et al
    Management of left main coronary artery obstruction after transcatheter aortic valve replacement utilizing a periscope approach.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27317.
    PubMed     Text format     Abstract available


  77. GIANNINI F, Latib A, Montorfano M, Ruparelia N, et al
    A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27319.
    PubMed     Text format     Abstract available


  78. YAHAGI K, Torii S, Ladich E, Kutys R, et al
    Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27314.
    PubMed     Text format     Abstract available


  79. VAN GILS L, Kroon H, Daemen J, Ren C, et al
    Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27323.
    PubMed     Text format     Abstract available


  80. ANDO T, Takagi H, Briasoulis A, Telila T, et al
    A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions.
    Catheter Cardiovasc Interv. 2017 Sep 1. doi: 10.1002/ccd.27256.
    PubMed     Text format     Abstract available


    August 2017
  81. DHOBLE A, Bhise V, Nevah MI, Balan P, et al
    Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
    Catheter Cardiovasc Interv. 2017 Aug 28. doi: 10.1002/ccd.27232.
    PubMed     Text format     Abstract available


  82. HUCZEK Z, Zbronski K, Grodecki K, Scislo P, et al
    Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Catheter Cardiovasc Interv. 2017 Aug 26. doi: 10.1002/ccd.27251.
    PubMed     Text format     Abstract available


  83. ALKHALIL A, Lamba H, Deo S, Bezerra HG, et al
    Safety of shorter length of hospital stay for patients undergoing minimalist transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 24. doi: 10.1002/ccd.27230.
    PubMed     Text format     Abstract available


  84. KRISHNAN S, Daniels D, McCabe JM
    Novel bipolar preshaped left ventricular pacing wire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 11. doi: 10.1002/ccd.27244.
    PubMed     Text format    


  85. BHARADWAJ AS, Bhatheja S, Sharma SK, Kini AS, et al
    Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27211.
    PubMed     Text format     Abstract available


  86. TELILA T, Akintoye E, Ando T, Merid O, et al
    Hospital teaching status and trascatheter aortic valve replacement outcomes in the United States: Analysis of the national inpatient sample.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27236.
    PubMed     Text format     Abstract available


  87. WATERBURY TM, Reeder GS, Pislaru SV, Cabalka AK, et al
    Techniques and outcomes of paravalvular leak repair after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 2. doi: 10.1002/ccd.27224.
    PubMed     Text format     Abstract available


  88. KHAN JM, Lederman RJ
    Unnatural milieu: Thrombus after transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2017;90:329-330.
    PubMed     Text format     Abstract available


  89. FELDMAN T, Guerrero M
    Balloon aortic valvuloplasty in the TAVR era: Not so new but definitely improved.
    Catheter Cardiovasc Interv. 2017;90:311-312.
    PubMed     Text format     Abstract available


    July 2017
  90. VILLABLANCA PA, Mohananey D, Nikolic K, Bangalore S, et al
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Jul 24. doi: 10.1002/ccd.27207.
    PubMed     Text format     Abstract available


  91. CLAESSEN BE, van den Boogert TPW, Piek JJ
    Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?
    Catheter Cardiovasc Interv. 2017 Jul 12. doi: 10.1002/ccd.27186.
    PubMed     Text format     Abstract available


    June 2017
  92. KOEHLE M, Strote JA, Guadagnoli M, Oldemeyer JB, et al
    A novel mechanical mitral valve replacement using Sapien XT.
    Catheter Cardiovasc Interv. 2017 Jun 9. doi: 10.1002/ccd.27149.
    PubMed     Text format     Abstract available


  93. YAHAGI K, Ladich E, Kutys R, Mori H, et al
    Pathology of balloon-expandable transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27160.
    PubMed     Text format     Abstract available


  94. EL-SAID HG, Pockett CR, Moore JW
    Percutaneous obliteration of left ventricular cavity to eliminate aortic regurgitation and presumed coronary steal in an infant with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27138.
    PubMed     Text format     Abstract available


  95. ORVIN K, Kornowski R
    The problem of delirium following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017;89:1292-1293.
    PubMed     Text format     Abstract available


  96. KUO JA, Feezel AA, Putnam TN, Schutte DA, et al
    Melody valve implantation within freestyle stentless porcine aortic heterograft.
    Catheter Cardiovasc Interv. 2017;89:1224-1230.
    PubMed     Text format     Abstract available


    May 2017
  97. GUERRERO M, Salinger M, Pursnani A, Pearson P, et al
    Transseptal transcatheter mitral valve-in-valve: A step by step guide from preprocedural planning to postprocedural care.
    Catheter Cardiovasc Interv. 2017 May 30. doi: 10.1002/ccd.27128.
    PubMed     Text format     Abstract available


  98. DOERNER J, Kupczyk PA, Wilsing M, Luetkens JA, et al
    Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2017 May 26. doi: 10.1002/ccd.27122.
    PubMed     Text format     Abstract available


  99. HO EC, Ahmed N, Connelly KA, Fam NP, et al
    Transcatheter edge-to-edge repair of anterior mitral flail through a dehisced annuloplasty ring.
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27126.
    PubMed     Text format     Abstract available


  100. WITBERG G, Finkelstein A, Barbash I, Assali A, et al
    Prognostic significance of aortic valve gradient in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27124.
    PubMed     Text format     Abstract available


  101. TARAMASSO M, Denegri A, Kuwata S, Rickli H, et al
    Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27100.
    PubMed     Text format     Abstract available


  102. LINKE A, Chandrasekhar J, Sartori S, Lefevre T, et al
    Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial.
    Catheter Cardiovasc Interv. 2017 May 12. doi: 10.1002/ccd.27154.
    PubMed     Text format     Abstract available


  103. HENGSTENBERG C, Chandrasekhar J, Sartori S, Lefevre T, et al
    Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial.
    Catheter Cardiovasc Interv. 2017 May 11. doi: 10.1002/ccd.27155.
    PubMed     Text format     Abstract available


  104. GEORGE B, Voelkel A, Kotter J, Leventhal A, et al
    A novel approach to percutaneous removal of large tricuspid valve vegetations using suction filtration and veno-venous bypass: A single center experience.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27097.
    PubMed     Text format     Abstract available


  105. CONDADO JF, Corrigan FE 3rd, Lerakis S, Parastatidis I, et al
    Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26987.
    PubMed     Text format     Abstract available


  106. BRUNNER NW, Yue SF, Stub D, Ye J, et al
    The prognostic importance of the diastolic pulmonary gradient, transpulmonary gradient, and pulmonary vascular resistance in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27107.
    PubMed     Text format     Abstract available


  107. GREENBAUM AB, Condado JF, Eng M, Lerakis S, et al
    Long or redundant leaflet complicating transcatheter mitral valve replacement: Case vignettes that advocate for removal or reduction of the anterior mitral leaflet.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27054.
    PubMed     Text format     Abstract available


  108. SALNA M, Khalique OK, Chiuzan C, Kurlansky P, et al
    Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27120.
    PubMed     Text format     Abstract available


  109. OKOH AK, Chauhan D, Kang N, Haik N, et al
    The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 May 2. doi: 10.1002/ccd.27083.
    PubMed     Text format     Abstract available


  110. ALRAIES MC, Satler LF
    End-stage renal disease and severe aortic stenosis. Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv. 2017;89:1116-1117.
    PubMed     Text format    


    April 2017
  111. HERRMANN HC, Szeto WY, Litt H, Vernick W, et al
    Novel use of perfusion balloon inflation to avoid outflow tract obstruction during transcatheter mitral valve-in-valve replacement.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27068.
    PubMed     Text format     Abstract available


  112. AUFFRET V, Regueiro A, Campelo-Parada F, Del Trigo M, et al
    Feasibility, safety, and efficacy of transcatheter aortic valve replacement without balloon predilation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 12. doi: 10.1002/ccd.27040.
    PubMed     Text format     Abstract available


  113. SARDAR P, Kundu A, Chatterjee S, Feldman DN, et al
    Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 11. doi: 10.1002/ccd.27041.
    PubMed     Text format     Abstract available


  114. RUIZ CE, Chi-Hion L, Vladimir J, Gila P, et al
    Hopscotch technique: A novel method for percutaneous closure of paravalvular leaks.
    Catheter Cardiovasc Interv. 2017;89:944-950.
    PubMed     Text format     Abstract available


    March 2017
  115. YOUNG MN, Elmariah S, Kennedy KF, Inglessis I, et al
    Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.
    Catheter Cardiovasc Interv. 2017 Mar 22. doi: 10.1002/ccd.27018.
    PubMed     Text format     Abstract available


  116. TANG GH, Cohen M, Dutta T, Undemir C, et al
    Afterload mismatch after transcatheter mitral valve repair with MitraClip for degenerative mitral regurgitation in acute cardiogenic shock.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27019.
    PubMed     Text format     Abstract available


  117. MOHAMMAD NIJRES B, Kenny D, Kazmouz S, Hijazi ZM, et al
    Transcatheter closure of unroofed coronary sinus using covered stents in an adult with drainage of the coronary sinus to the right ventricle after supra-annular tricuspid valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26996.
    PubMed     Text format     Abstract available


  118. KHERADA N, Brenes JC, Kini AS, Dangas GD, et al
    Assessment of trans-aortic pressure gradient using a coronary pressure wire in patients with mechanical aortic and mitral valve prostheses.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26962.
    PubMed     Text format     Abstract available


  119. DEUSCHL F, Schofer N, Seiffert M, Hakmi S, et al
    Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26986.
    PubMed     Text format     Abstract available


  120. KOIFMAN E, Patel N, Weissman G, Kiramijyan S, et al
    Outcome of implantation of a second self-expanding valve for the treatment of residual significant aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26960.
    PubMed     Text format     Abstract available


  121. SUMMERS MR, Mick S, Kapadia SR, Krishnaswamy A, et al
    Emergency valve-in-valve transcatheter aortic valve replacement in a patient with degenerated bioprosthetic aortic stenosis and cardiogenic shock on veno-arterial extracorporeal membrane oxygenation.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26990.
    PubMed     Text format     Abstract available


  122. AL'AREF SJ, Devereux RB, Cheung JW, Bergman G, et al
    Bioprosthetic mitral valve paravalvular leak closure using intracardiac echocardiography-guided three dimensional electroanatomic mapping.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26958.
    PubMed     Text format     Abstract available


  123. ARAI T, Lefevre T, Hovasse T, Garot P, et al
    Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
    PubMed     Text format     Abstract available


  124. MEDURI C, Kauten J, Vannan M, Rajagopal V, et al
    First report of a simultaneous transcatheter mitral valve-in-valve and aortic valve replacement in a left ventricular assist device patient.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26983.
    PubMed     Text format     Abstract available


  125. GUERRERO M, Wang DD, Himbert D, Urena M, et al
    Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26975.
    PubMed     Text format     Abstract available


  126. VEJPONGSA P, Bhise V, Charitakis K, Vernon Anderson H, et al
    Early readmissions after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 2. doi: 10.1002/ccd.26945.
    PubMed     Text format     Abstract available


  127. LIAO YB, Zhao ZG, Wei X, Xu YN, et al
    Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: Preliminary Experiences in China.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  128. CAIXETA A, Lemos PA
    Transcatheter aortic valve replacement by a minimalist approach: A breath of fresh air for patients with chronic obstructive pulmonary disease.
    Catheter Cardiovasc Interv. 2017;89:781-782.
    PubMed     Text format    


  129. HEIN-ROTHWEILER R, Jochheim D, Rizas K, Egger A, et al
    Aortic annulus to left coronary distance as a predictor for persistent left bundle branch block after TAVI.
    Catheter Cardiovasc Interv. 2017;89:E162-E168.
    PubMed     Text format     Abstract available


  130. STEINVIL A, Satler L
    Does the removal of the temporary pacer wire for BAV and TAVR really simplify the procedure?
    Catheter Cardiovasc Interv. 2017;89:787-788.
    PubMed     Text format    


    February 2017
  131. CONDADO JF, Maini A, Leshnower B, Thourani V, et al
    End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv. 2017 Feb 17. doi: 10.1002/ccd.26875.
    PubMed     Text format     Abstract available


  132. JAMES RODRIGUEZ R, Prasad A
    Transcatheter aortic valve replacement and renal function: A complex relationship.
    Catheter Cardiovasc Interv. 2017;89:460-461.
    PubMed     Text format    


  133. CONDADO JF, Block PC
    Gender inequalities in transcatheter aortic valve replacement: The jury is still out.
    Catheter Cardiovasc Interv. 2017;89:436-437.
    PubMed     Text format    


  134. COOLS B, Rega F, Gewillig M
    Transhepatic implant of a trimmed Melody valved stent in tricuspid position in a 1-year-old infant.
    Catheter Cardiovasc Interv. 2017;89:E84-E89.
    PubMed     Text format     Abstract available


  135. PELBERG J, Gray WA
    Good to great: TAVR tackles stroke risk.
    Catheter Cardiovasc Interv. 2017;89:478-479.
    PubMed     Text format    


  136. YADAV PK, Gilchrist IC
    Significant leak after TAVR: A plug is an option.
    Catheter Cardiovasc Interv. 2017;89:468-469.
    PubMed     Text format    


  137. RAKITA V, Lakhter V, Patil P, O'Neill BP, et al
    Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2017 Feb 7. doi: 10.1002/ccd.26931.
    PubMed     Text format     Abstract available


  138. SORAJJA P, Kanda B, Bae R, Pedersen WA, et al
    Maneuvers for technical success with transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26899.
    PubMed     Text format     Abstract available


  139. CZARNECKI A, Qiu F, Koh M, Prasad TJ, et al
    Clinical outcomes after trans-catheter aortic valve replacement in men and women in Ontario, Canada.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26906.
    PubMed     Text format     Abstract available


  140. MONTONE RA, Testa L, Fraccaro C, Montorfano M, et al
    Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26914.
    PubMed     Text format     Abstract available


  141. SHAH AH, Horlick EM, Eicken A, Asnes JD, et al
    Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Bjork-fontan procedure.
    Catheter Cardiovasc Interv. 2017;89:298-305.
    PubMed     Text format     Abstract available


  142. HAGLER DJ
    The Lababidi Procedure: Is Neonatal Balloon Aortic Valvotomy Worth the Risk?
    Catheter Cardiovasc Interv. 2017;89:296-297.
    PubMed     Text format    


    January 2017
  143. HORN P, Hellhammer K, Minier M, Stenzel MA, et al
    Deep sedation Vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip(R) system.
    Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26884.
    PubMed     Text format     Abstract available


  144. ABDELGHANI M, Tateishi H, Miyazaki Y, Cavalcante R, et al
    Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: Echocardiographic and clinical correlates.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26926.
    PubMed     Text format     Abstract available


  145. MCCABE JM, Dean LS
    Pass the Rock: calcium, the achilles heel of transcatheter valve replacement.
    Catheter Cardiovasc Interv. 2017;89:142-143.
    PubMed     Text format     Abstract available


    December 2016
  146. JATENE T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, et al
    Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26837.
    PubMed     Text format     Abstract available


  147. RASMUSSEN VG, Kanstrup HL, Nielsen-Kudsk JE
    Percutaneous balloon valvuloplasty in carcinoid pulmonary valve stenosis.
    Catheter Cardiovasc Interv. 2016;88:1174-1176.
    PubMed     Text format     Abstract available


  148. MILLAN X, Azzalini L, Khan R, Cournoyer D, et al
    Efficacy of a balloon-expandable vascular access system in transfemoral TAVI patients.
    Catheter Cardiovasc Interv. 2016;88:1145-1152.
    PubMed     Text format     Abstract available


  149. CILINGIROGLU M, Marmagkiolis K
    Invasive Hemodynamic Assessment During Mitra-Clip Implantation: Should It Be the New Standard?
    Catheter Cardiovasc Interv. 2016;88:1143-1144.
    PubMed     Text format     Abstract available


    November 2016
  150. FETTERLY K, Greason K, Mathew V
    Balloon Valvuloplasty to Predict X-ray Projection Angles that are Perpendicular to Cardiovascular Structures: A TAVI Patient Feasibility Study.
    Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26879.
    PubMed     Text format     Abstract available


  151. MASSUMI M, Krajcer Z
    To BAV or not to BAV, that is a TAVR question.
    Catheter Cardiovasc Interv. 2016;88:986-987.
    PubMed     Text format    


  152. YADAV PK, Eng MH
    A toast to no sternotomy.
    Catheter Cardiovasc Interv. 2016;88:960-961.
    PubMed     Text format    


  153. GUERRERO I, Dhoble A, Fasulo M, Denktas AE, et al
    Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:971-977.
    PubMed     Text format     Abstract available


  154. FAURIE B, Abdellaoui M, Wautot F, Staat P, et al
    Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures.
    Catheter Cardiovasc Interv. 2016;88:988-993.
    PubMed     Text format     Abstract available


  155. RUPARELIA N, Mangieri A, Ancona M, Giannini F, et al
    Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure.
    Catheter Cardiovasc Interv. 2016;88:994-1001.
    PubMed     Text format     Abstract available


  156. FORTUNATO DE CANO S, Nicolas Cano M, de Ribamar Costa J Jr, Alves Pinheiro J Jr, et al
    Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:953-960.
    PubMed     Text format     Abstract available


  157. CORRIGAN FE 3RD, Douglas JS Jr
    Now you see me, now you don't: The case of a vanishing outflow gradient in a patient with hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:1006-1009.
    PubMed     Text format     Abstract available


  158. PRASAD M, Geske JB, Sorajja P, Ommen SR, et al
    Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction.
    Catheter Cardiovasc Interv. 2016;88:962-970.
    PubMed     Text format     Abstract available


  159. LIEBREGTS M, Vriesendorp PA, Steggerda RC, Schinkel AF, et al
    Effect of alcohol dosage on long-term outcomes after alcohol septal ablation in patients with hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:945-952.
    PubMed     Text format     Abstract available


  160. KAWASE Y, Matsuo H
    A modified method (MK method) of alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopahty.
    Catheter Cardiovasc Interv. 2016;88:1002-1005.
    PubMed     Text format     Abstract available


  161. CONDADO JF, Haider MN, Lerakis S, Keegan P, et al
    Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?
    Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26683.
    PubMed     Text format     Abstract available


  162. ZAMAN S, McCormick L, Gooley R, Rashid H, et al
    Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus transcatheter aortic valve.
    Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26857.
    PubMed     Text format     Abstract available


  163. CONROTTO F, D'Ascenzo F, D'Amico M, Moretti C, et al
    Outcomes of patients with low-pressure aortic gradient undergoing transcatheter aortic valve implantation: A Meta-analysis.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26839.
    PubMed     Text format     Abstract available


  164. PICARD F, Tadros VX, Asgar AW
    From tricuspid to double orifice Morphology: Percutaneous tricuspid regurgitation repair with the MitraClip device in congenitally corrected-transposition of great arteries.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26834.
    PubMed     Text format     Abstract available


  165. MCELHINNEY DB
    Hybrid transcatheter pulmonary valve replacement: Moving into the mainstream?
    Catheter Cardiovasc Interv. 2016;88:811-813.
    PubMed     Text format    


  166. SOSNOWSKI C, Matella T, Fogg L, Ilbawi M, et al
    Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: Comparison with surgical PVR.
    Catheter Cardiovasc Interv. 2016;88:804-810.
    PubMed     Text format     Abstract available


  167. LINDSAY I, Aboulhosn J, Salem M, Levi D, et al
    Aortic root compression during transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2016;88:814-821.
    PubMed     Text format     Abstract available


  168. PATIL NC, Saxena A, Gupta SK, Juneja R, et al
    Perforating the atretic pulmonary valve with CTO hardware: Technical aspects.
    Catheter Cardiovasc Interv. 2016;88:E145-E150.
    PubMed     Text format     Abstract available


  169. CHAKRABORTY S, Vadivelu R, Bagga S
    Percutaneous balloon mitral valvuloplasty under neuroprotection: Too Early for Knighthood.
    Catheter Cardiovasc Interv. 2016;88:E151-E154.
    PubMed     Text format     Abstract available


    October 2016
  170. KODAMA A, Yamamoto M, Shimura T, Kagase A, et al
    Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Catheter Cardiovasc Interv. 2016 Oct 27. doi: 10.1002/ccd.26686.
    PubMed     Text format     Abstract available


  171. KISCHE S, D'Ancona G, Agma HU, El-Achkar G, et al
    Trans-catheter aortic valve implantation with the direct flow medical prosthesis: Single center short-term clinical and echocardiographic outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26528.
    PubMed     Text format     Abstract available


  172. D'ANCONA G, Agma HU, Ince H, El-Achkar G, et al
    Transcatheter aortic valve implantation with the direct flow medical prosthesis: Impact of native aortic valve calcification degree on outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26517.
    PubMed     Text format     Abstract available


  173. HILLING-SMITH R, Cockburn J, Dooley M, Parker J, et al
    Rapid pacing using the 0.035-in. Retrograde left ventricular support wire in 208 cases of transcatheter aortic valve implantation and balloon aortic valvuloplasty.
    Catheter Cardiovasc Interv. 2016 Oct 11. doi: 10.1002/ccd.26720.
    PubMed     Text format     Abstract available


  174. LOYALKA P, Nascimbene A, Schechter M, Petrovic M, et al
    Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26723.
    PubMed     Text format     Abstract available


  175. LANDES U, Sagie A, Kornowski R
    Transcatheter aortic valve implantation in degenerative sutureless perceval aortic bioprosthesis.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26576.
    PubMed     Text format     Abstract available


  176. SCHNEIDER AE, Delaney JW, Cabalka AK
    Non-infectious thrombosis of the melody(R) valve: A tale of two cities.
    Catheter Cardiovasc Interv. 2016;88:600-604.
    PubMed     Text format     Abstract available


  177. YILDIRIM A, Goktekin O, Gorgulu S, Norgaz T, et al
    A New Specific Device in Transcatheter Prosthetic Paravalvular Leak Closure: A Prospective Two-Center Trial.
    Catheter Cardiovasc Interv. 2016;88:618-624.
    PubMed     Text format     Abstract available


  178. DAVIDSON LJ, Davidson CJ
    Stroke Prevention: Let's Prepare for Generation X TAVR.
    Catheter Cardiovasc Interv. 2016;88:653-655.
    PubMed     Text format     Abstract available


    September 2016
  179. ACHARJI S, Agnihotri A, Carrozza J
    Transcatheter aortic valve replacement in unicuspid aortic valve stenosis (CCI-16-0461).
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26798.
    PubMed     Text format     Abstract available


  180. HARPER AR, Dawkins S, Newton JD
    Late subannular aortic root rupture following transcatheter aortic valve implantation presenting as ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26724.
    PubMed     Text format     Abstract available


  181. SULLIVAN PM, Rubio AE, Johnston TA, Jones TK, et al
    Long-term outcomes and re-interventions following balloon aortic valvuloplasty in pediatric patients with congenital aortic stenosis: A single-center study.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26722.
    PubMed     Text format     Abstract available


  182. HAMM K, Zacher M, Hautmann M, Gietzen F, et al
    Influence of experience on procedure steps, safety, and functional results in edge to edge mitral valve repair-a single center study.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26806.
    PubMed     Text format     Abstract available


  183. OKUYAMA K, Chakravarty T, Makkar RR
    Percutaneous transapical pseudoaneurysm closure following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Sep 13. doi: 10.1002/ccd.26494.
    PubMed     Text format     Abstract available



  184. Aortic Regurgitation Following Transcatheter Aortic Valve Replacement: Impact of Preprocedural Left Ventricular Diastolic Filling Patterns on Late Clinical Outcomes. DOI: 10.1002/ccd.26298.
    Catheter Cardiovasc Interv. 2016;88:500.
    PubMed     Text format    


  185. BROWN SC, Cools B, Gewillig M
    Cracking a tricuspid perimount bioprosthesis to optimize a second transcatheter sapien valve-in-valve placement.
    Catheter Cardiovasc Interv. 2016;88:456-9.
    PubMed     Text format     Abstract available


  186. FELDMAN T, Pearson P, Smart SS
    Percutaneous closure of post TAVR LV apical pseudoaneurysm.
    Catheter Cardiovasc Interv. 2016;88:479-85.
    PubMed     Text format     Abstract available


  187. KORNOWSKI R
    The 3 S's of the Sapien balloon expandable valve.
    Catheter Cardiovasc Interv. 2016;88:476-8.
    PubMed     Text format     Abstract available


    August 2016
  188. JIVANJI SG, Derrick G, Khambadkone S
    Doubly committed subarterial ventricular septal defect: A risk factor for aortic distortion in patients considered for percutaneous pulmonary valve implantation?
    Catheter Cardiovasc Interv. 2016;88:244-7.
    PubMed     Text format     Abstract available


  189. SPITZER SG, Wilbring M, Alexiou K, Stumpf J, et al
    Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI?
    Catheter Cardiovasc Interv. 2016;88:E52-8.
    PubMed     Text format     Abstract available


  190. CAMMALLERI V, Romeo F, Ussia GP
    Hemodynamic complications during transcatheter MitraClip repair in presence of congenital atrial septal defect.
    Catheter Cardiovasc Interv. 2016;88:307-11.
    PubMed     Text format     Abstract available


  191. SAFIAN RD, Hanzel G
    Management of vascular access after TAVR: Let's keep it simple.
    Catheter Cardiovasc Interv. 2016;88:285-6.
    PubMed     Text format     Abstract available


    July 2016
  192. ABU SALEH WK, Tang GH, Ahmad H, Cohen M, et al
    Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.
    Catheter Cardiovasc Interv. 2016;88:135-43.
    PubMed     Text format     Abstract available


  193. SEGUELA PE, Roubertie F, Thambo JB
    Distortion of the left anterior descending coronary artery after pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2016;88:99-102.
    PubMed     Text format     Abstract available


  194. SINGH K, Qutub M, Carson K, Hibbert B, et al
    A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
    Catheter Cardiovasc Interv. 2016;88:107-15.
    PubMed     Text format     Abstract available


  195. FRISOLI TM, Guerrero M, O'Neill WW
    Mechanical circulatory support with impella to facilitate percutaneous coronary intervention for post-TAVI bilateral coronary obstruction.
    Catheter Cardiovasc Interv. 2016;88:E34-7.
    PubMed     Text format     Abstract available


  196. YADAV PK, Eng MH
    Size does matter but is there an obesity paradox in TAVR?
    Catheter Cardiovasc Interv. 2016;88:125-6.
    PubMed     Text format     Abstract available


  197. BADER Y, Kimmelstiel C
    Ablation or surgery for medically refractory HCM. Updating an imperfect dataset.
    Catheter Cardiovasc Interv. 2016;88:116-7.
    PubMed     Text format     Abstract available


    June 2016
  198. GILCHRIST IC, Hansen J
    Between a rock and a hard place: TAVR and ESRD.
    Catheter Cardiovasc Interv. 2016;87:1322-3.
    PubMed     Text format     Abstract available


    April 2016
  199. INOHARA T, Hayashida K, Watanabe Y, Yamamoto M, et al
    Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries.
    Catheter Cardiovasc Interv. 2016;87:963-70.
    PubMed     Text format     Abstract available


  200. FUJITA B, Scholtz S, Ensminger S
    Valve-in-valve using an Edwards Sapien XT into a JenaValve in a patient with a low originating left coronary artery and a heavily calcified aorta.
    Catheter Cardiovasc Interv. 2016;87:989-92.
    PubMed     Text format     Abstract available


    March 2016
  201. BOE BA, Bocks ML, Armstrong AK
    Contained rupture of patched right ventricular outflow tracts during balloon sizing for percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2016;87:768-72.
    PubMed     Text format     Abstract available


  202. ELEID MF, Asirvatham SJ, Cabalka AK, Hagler DJ, et al
    Transcatheter tricuspid valve-in-valve in patients with transvalvular device leads.
    Catheter Cardiovasc Interv. 2016;87:E160-5.
    PubMed     Text format     Abstract available


    February 2016
  203. PHILLIPS AB, Nevin P, Shah A, Olshove V, et al
    Development of a novel hybrid strategy for transcatheter pulmonary valve placement in patients following transannular patch repair of tetralogy of fallot.
    Catheter Cardiovasc Interv. 2016;87:403-10.
    PubMed     Text format     Abstract available


  204. MULLER B, Ghawi H, Heitschmidt MG, Fogg L, et al
    Medium-term CT evaluation of stent geometry, integrity, and valve function of the Edwards SAPIEN transcatheter heart valve in the pulmonary position.
    Catheter Cardiovasc Interv. 2016;87:E97-103.
    PubMed     Text format     Abstract available


  205. SMOLKA G, Pysz P, Jasinski M, Roleder T, et al
    Multiplug paravalvular leak closure using Amplatzer Vascular Plugs III: A prospective registry.
    Catheter Cardiovasc Interv. 2016;87:478-87.
    PubMed     Text format     Abstract available


    January 2016
  206. TOMMASO CL
    Learning curves for TAVR: Not quite see one, do one teach one.
    Catheter Cardiovasc Interv. 2016;87:163-4.
    PubMed     Text format     Abstract available


  207. CILINGIROGLU M, Marmagkiolis K
    A glimpse into the future of TAVR.
    Catheter Cardiovasc Interv. 2016;87:152-3.
    PubMed     Text format     Abstract available


  208. HOLZER RJ, Hijazi ZM
    Transcatheter pulmonary valve replacement: State of the art.
    Catheter Cardiovasc Interv. 2016;87:117-28.
    PubMed     Text format     Abstract available


  209. NOAD RL, Johnston N, McKinley A, Dougherty M, et al
    A pathway to earlier discharge following TAVI: Assessment of safety and resource utilization.
    Catheter Cardiovasc Interv. 2016;87:134-42.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: